FindTrial
Sign In

Effect of Dexmedetomidine in reducing fasciculations and muscle ache caused by the drug Succinylcholine in patients undergoing electroconvulsive therapy

Evaluation of effect of Dexmedetomidine on Succinylcholine induced fasciculations and myalgia in patients undergoing electroconvulsive therapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096775
Enrollment
50
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F319- Bipolar disorder, unspecified Health Condition 2: F22- Delusional disorders Health Condition 3: F429- Obsessive-compulsive disorder, unspecified Health Condition 4: F200- Paranoid schizophrenia Health Condition 5: F209- Schizophrenia, unspecified

Interventions

Intervention1: DEXMEDETOMIDINE: Patients in the control group are given 10 ml normal saline IV. Patients in the dexmedetomidine group are given dexmedetomidine 0.25 mcg/kg IV diluted in 10 ml normal s

Sponsors

VMMC and Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of the American Society of Anesthesiologists (ASA) physical status I/II aged 18–65 years undergoing ECT at VMMC and Safdarjung Hospital

Exclusion criteria

Exclusion criteria: Blind or deaf patients Allergic to dexmedetomidine Second- or third-degree heart block or persistent bradycardia Taking beta blockers or other antiarrhythmic drugs Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
1. Succinylcholine induced fasciculations 2. Succinylcholine induced myalgia 30 minutes after the procedureTimepoint: 1. Succinylcholine induced fasciculations 2. Succinylcholine induced myalgia 30 minutes after the procedure—

Secondary

MeasureTime frame
Hemodynamic parameters - Heart rate - Blood pressure and mean arterial pressure - Oxygen saturation before the procedure, during the procedure, 5 minutes,10 minutes and 20 minutes after the procedure.Timepoint: Hemodynamic parameters - Heart rate - Blood pressure and mean arterial pressure - Oxygen saturation before the procedure, during the procedure, 5 minutes,10 minutes and 20 minutes after the procedure.—

Countries

India

Contacts

Public ContactVIDYA V

VMMC and Safdarjung Hospital

drmadhudayal@gmail.com9811271996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026